Modicus Prime, resident at Johnson & Johnson Innovation – JLABS @ TMC, has received $3.5 million in funding led by Silverton Partners, with additional backing from Alumni Ventures and other leading venture firms. The funding follows the implementation of Modicus Prime’s mpVision, a Pharma 4.0 quality control technology, across multiple global pharmaceutical companies, CMOs, and CDMOs manufacturing biologics, cell and gene therapies, and vaccines. The cloud software is designed to s...